Furthermore, anti-TNFR1 mono-treatment could suppress the stem-like and metastatic properties of the CTGF-expressing cells, which revealed the specificity of TNFR1 in mediating the CTGF signaling in inducing tumor cell EMT. Here, CCN2 is linked to neoplasm.